1-[(2R)-Oxiran-2-ylmethyl]pyrrolidin-2-one

Catalog No.: 
ACLZPI523
CAS No.: 
409335-13-3
Molecular Formula: 
C7H11NO2
Molecular Weight: 
141.17
1-[(2R)-Oxiran-2-ylmethyl]pyrrolidin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$227.00InquiryInquiry
100mg95%$331.00InquiryInquiry
250mg95%$467.00InquiryInquiry
1g95%$925.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(2R)-Oxiran-2-ylmethyl]pyrrolidin-2-one
IUPAC Name(R)-1-(oxiran-2-ylmethyl)pyrrolidin-2-one
MDL No.MFCD18816849
Molecular FormulaC7H11NO2
Molecular Weight141.17
SMILESO=C1N(C[C@H]2OC2)CCC1
InChI KeyZNCCGGMWVUBVBO-ZCFIWIBFSA-N
Synonym2-Pyrrolidinone,1-[(2R)-oxiranylmethyl]-(9CI);1-[(2R)-oxiran-2-ylmethyl]pyrrolidin-2-one
CAS No.409335-13-3

Safety Data

Pictogram
CorrosiveHealth hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H312-H315-H319-H350
Precautionary Statement(s)
P201-P202-P210-P261-P264-P271-P280-P302+P352+P312-P305+P351+P338-P308+P313-P337+P313-P370+P378-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLZPI523 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLZPI523 route product structure diagram
    ACLZPI523409335-13-3
Inquiry

2. ACLZPI523 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLZPI523 route product structure diagram
    ACLZPI523409335-13-3
Inquiry

3. ACLZPI523 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLZPI523 route product structure diagram
    ACLZPI523409335-13-3
Inquiry

Comments (0)